- Home
- INO vs GEG Comparison
INO vs GEG Comparison
Compare INO & GEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INO
- GEG
- Stock Information
- Founded
- INO 1979
- GEG 1994
- Country
- INO United States
- GEG United States
- Employees
- INO N/A
- GEG N/A
- Industry
- INO Medical/Dental Instruments
- GEG Computer Software: Prepackaged Software
- Sector
- INO Health Care
- GEG Technology
- Exchange
- INO Nasdaq
- GEG Nasdaq
- Market Cap
- INO 69.3M
- GEG 63.0M
- IPO Year
- INO 1998
- GEG N/A
- Fundamental
- Price
- INO $1.96
- GEG $2.47
- Analyst Decision
- INO Buy
- GEG
- Analyst Count
- INO 5
- GEG 0
- Target Price
- INO $8.80
- GEG N/A
- AVG Volume (30 Days)
- INO 1.9M
- GEG 9.4K
- Earning Date
- INO 08-12-2025
- GEG 09-02-2025
- Dividend Yield
- INO N/A
- GEG N/A
- EPS Growth
- INO N/A
- GEG N/A
- EPS
- INO N/A
- GEG N/A
- Revenue
- INO $182,337.00
- GEG $19,626,000.00
- Revenue This Year
- INO N/A
- GEG N/A
- Revenue Next Year
- INO $20,588.06
- GEG N/A
- P/E Ratio
- INO N/A
- GEG N/A
- Revenue Growth
- INO N/A
- GEG 64.34
- 52 Week Low
- INO $1.30
- GEG $1.70
- 52 Week High
- INO $7.76
- GEG $2.54
- Technical
- Relative Strength Index (RSI)
- INO 66.94
- GEG 73.25
- Support Level
- INO $1.80
- GEG $2.06
- Resistance Level
- INO $2.08
- GEG $2.54
- Average True Range (ATR)
- INO 0.12
- GEG 0.10
- MACD
- INO 0.06
- GEG 0.04
- Stochastic Oscillator
- INO 82.35
- GEG 86.00
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About GEG Great Elm Group Inc.
Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.